Defendant Mix-Up Ends Biotech FCA Suit, For Now
By Gianna Ferrarin · February 9, 2026, 6:48 PM EST
A New York federal court ruled that a relator's False Claims Act suit failed to link claims of improper COVID-19 billing and other alleged schemes to defraud Medicare to the biotech...
To view the full article, register now.